{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Eatontown",
      "state": "NJ",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "64104",
      "recalling_firm": "West-ward Pharmaceutical Corp.",
      "address_1": "465 Industrial Way W",
      "address_2": "N/A",
      "postal_code": "07724-2209",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-201-2013",
      "product_description": "Carisoprodol Tablets, USP, 350 mg Rx Only, 100 tablets per bottle, Rx Only, Manufactured by: West-ward Pharmaceutical Corp., Eatontown, NJ 07724, NDC 0143-1176-01.",
      "product_quantity": "1763 bottles",
      "reason_for_recall": "Labeling: Not elsewhere classified: On 12/12/11, DEA published a final rule in the Federal Register making this product a schedule IV (C-IV)controlled substance.  This product is being recalled because this controlled product was not relabeled with the required \"C-IV\" imprint on the label for products distributed after the 06/11/12 deadline.",
      "recall_initiation_date": "20121130",
      "center_classification_date": "20130315",
      "termination_date": "20141218",
      "report_date": "20130327",
      "code_info": "Lot #: 69160A"
    }
  ]
}